[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Feeling the hype for Ardelyx $XXXX and climbing up XXXX% Don't sell just HODL 💎🙌 $ARDX"
X Link @JoyceBrook49465 2025-10-17T04:28Z X followers, XX engagements
"Top X Bullish Sentiment Cryptos: CROWD 🟩 $ARDX $BULLISH $SLX Top X Bullish Cryptos: MP 🟩 $LINK $NVDA $A Check out sentiment and other crypto stats at"
X Link @MarketProphit 2025-10-16T13:50Z 73.7K followers, XXX engagements
"$ARDX Raymond James Maintains Ardelyx With Buy Rating Maintains Target Price $XX Chris Raymond has covered the biopharma sector for over XX years covering a broad spectrum of large- mid- and small-cap biotechnology companies. He rejoined Raymond James in 2025 after seven years at Piper Sandler as a key leader in building their biopharma equity research practice. Prior to Piper Sandler he spent two years with Raymond James from 2015 to 2017 and prior to that spent XX years establishing and building the biopharma research effort at Robert W. Baird. @justfactstruth @crypto_biotech @n_hatami"
X Link @GhoutaNews 2025-10-16T08:19Z 2286 followers, XXX engagements
"You have to be a fool not to load this opportunity $ALEC $ALGS $ALLK $ALLR $ALLO $ALVR $ACOG $TKNO $ATHE $ALT $ALMS $ALVO $ALXO $ALZN $AMRN $AMLX $ANTX $ANIP $ANIX $ANNX $APGE $APLM $APLT $APRE $APVO $APM $APTO $AQST $ABUS $ARCT $ARDX $AVBP $ARTL $ARTV $AURA $AUPH $AUTL $AVDL"
X Link @BuyTheUgly 2025-10-14T16:23Z XX followers, XXX engagements